Aggregated
47% success rate- Bullish
- 0
- Hold
- 3
- Bearish
- 0
Mizuho
A Mizuho analyst with 32 tracked ratings across 21 distinct tickers has a 45.7% success rate on the captured sample, with a focus on bullish ratings, including 15 bullish and 4 hold ratings.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| RLMD | 2026-03-20 | buy | $19.00 | Aggregated |
| SRPT | 2026-03-13 | buy | $31.00 | Aggregated |
| QURE | 2026-03-11 | buy | $35.00 | Aggregated |
| QURE | 2026-03-03 | hold | $12.00 | Aggregated |
| ARQT | 2026-03-02 | buy | $35.00 | Aggregated |
| ACAD | 2026-02-23 | buy | $35.00 | Aggregated |
| QURE | 2025-12-09 | buy | $33.00 | Aggregated |
| ACAD | 2025-12-02 | hold | $29.00 | Aggregated |
| EOLS | 2025-12-02 | buy | $19.00 | Aggregated |
| ARQT | 2025-11-28 | buy | $37.00 | Aggregated |
| RLMD | 2025-11-19 | buy | $10.00 | Aggregated |
| RLMDRELMADA THERAPEUTICS INC | 2025-11-19 | unknown | $10.00 | Aggregated |
| SRPT | 2025-11-05 | buy | $26.00 | Aggregated |
| SRPTSAREPTA THERAPEUTICS INC | 2025-11-05 | unknown | $26.00 | Aggregated |
| ALKS | 2025-10-27 | buy | $45.00 | Aggregated |
| ALKSALKERMES PLC | 2025-10-27 | unknown | $45.00 | Aggregated |
| QUREUNIQURE N.V. | 2025-09-25 | unknown | $60.00 | Aggregated |
| MBX | 2025-09-24 | buy | $56.00 | Aggregated |
| MBXMBX BIOSCIENCES, INC. COMMON STOCK | 2025-09-24 | unknown | $56.00 | Aggregated |
| ACAD | 2025-08-07 | hold | $24.00 | Aggregated |
| MBX | 2025-08-05 | buy | $38.00 | Aggregated |
| ACADACADIA PHARMACEUTICALS INC | 2025-05-19 | hold | $23.00 | Aggregated |
| TECXTECTONIC THERAPEUTIC INC. | 2025-04-21 | unknown | $51.00 | Aggregated |
| ARQT | 2025-02-26 | buy | $21.00 | Aggregated |
| ARQTARCUTIS BIOTHERAPEUTICS INC | 2025-02-26 | unknown | $21.00 | Aggregated |
| ARQT | 2025-01-07 | buy | $20.00 | Aggregated |
| RLMD | 2024-12-05 | hold | $1.00 | Aggregated |
| RLMDRELMADA THERAPEUTICS INC | 2024-12-05 | hold | $1.00 | Aggregated |
| NBIXNEUROCRINE BIOSCIENCES, INC. | 2024-02-08 | hold | $140.00 | Aggregated |
| RVNCREVANCE THERAPEUTICS INC | 2023-11-22 | unknown | $16.00 | Aggregated |
| EOLSEVOLUS INC | 2023-06-07 | unknown | $20.00 | Aggregated |
| JNJJOHNSON & JOHNSON | 2023-06-07 | unknown | $40.00 | Aggregated |
| OCGNOCUGEN INC | 2023-03-01 | unknown | $3.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| RLMD | 3 | 2026-03-20 | Aggregated |
| SRPT | 2 | 2026-03-13 | Aggregated |
| QURE | 3 | 2026-03-11 | Aggregated |
| ARQT | 4 | 2026-03-02 | Aggregated |
| ACAD | 3 | 2026-02-23 | Aggregated |
| EOLS | 1 | 2025-12-02 | Aggregated |
| RLMDRELMADA THERAPEUTICS INC | 2 | 2025-11-19 | Aggregated |
| SRPTSAREPTA THERAPEUTICS INC | 1 | 2025-11-05 | Aggregated |
| ALKS | 1 | 2025-10-27 | Aggregated |
| ALKSALKERMES PLC | 1 | 2025-10-27 | Aggregated |
| QUREUNIQURE N.V. | 1 | 2025-09-25 | Aggregated |
| MBX | 2 | 2025-09-24 | Aggregated |
| MBXMBX BIOSCIENCES, INC. COMMON STOCK | 1 | 2025-09-24 | Aggregated |
| ACADACADIA PHARMACEUTICALS INC | 1 | 2025-05-19 | Aggregated |
| TECXTECTONIC THERAPEUTIC INC. | 1 | 2025-04-21 | Aggregated |
| ARQTARCUTIS BIOTHERAPEUTICS INC | 1 | 2025-02-26 | Aggregated |
| NBIXNEUROCRINE BIOSCIENCES, INC. | 1 | 2024-02-08 | Aggregated |
| RVNCREVANCE THERAPEUTICS INC | 1 | 2023-11-22 | Aggregated |
| EOLSEVOLUS INC | 1 | 2023-06-07 | Aggregated |
| JNJJOHNSON & JOHNSON | 1 | 2023-06-07 | Aggregated |
| OCGNOCUGEN INC | 1 | 2023-03-01 | Aggregated |